Press Release: Danimer Scientific Announces First Quarter 2024 Results

Dow Jones05-08
                                               -------    ------- 
Cash flows from investing activities: 
    Purchases of property, plant and 
     equipment and intangible assets            (1,970)   (16,400) 
                                               -------    ------- 
            Net cash used in investing 
             activities                         (1,970)   (16,400) 
                                               -------    ------- 
Cash flows from financing activities: 
    Proceeds from issuance of common 
     warrants, net of issuance costs             8,883          - 
    Proceeds from issuance of common stock, 
     net of issuance costs                       4,650          - 
    Principal payments on long-term debt          (606)    (5,494) 
    Proceeds from employee stock purchase 
     plan                                          118        129 
    Employee taxes related to stock-based 
     compensation                                   (8)       (61) 
    Proceeds from long-term debt                     -    130,000 
    Cash paid for debt issuance costs                -    (33,035) 
                                               -------    ------- 
            Net cash provided by financing 
             activities                         13,037     91,539 
                                               -------    ------- 
                Net (decrease) increase in 
                 cash and cash equivalents 
                 and restricted cash            (1,924)    69,274 
                                               -------    ------- 
Cash and cash equivalents and restricted 
 cash-beginning of period                       73,504     64,401 
                                               -------    ------- 
Cash and cash equivalents and restricted 
 cash-end of period                           $ 71,580   $133,675 
                                               =======    ======= 
 

Non-GAAP Financial Measures

This press release includes the non-GAAP financial measures "Adjusted EBITDA", "Adjusted gross profit" and "Adjusted gross margin". Danimer management views these metrics as a useful way to look at the performance of its operations between periods and to exclude decisions on capital investment and financing that might otherwise impact the review of profitability of the business based on present market conditions.

Adjusted EBITDA is defined as net income or loss plus net interest expense, income taxes, depreciation and amortization, as adjusted to add back certain charges or gains that Danimer may record each period such as remeasurement of private warrants, stock-based compensation expense, as well as non-recurring charges such as (i) asset disposal gains or losses as well as other significant gains or losses such as debt extinguishments and impairment of goodwill; (ii) legal settlements; or (iii) other discrete non-recurring items. Danimer believes these items are not considered an indicator of ongoing performance. Adjusted EBITDA is not a measure of performance defined in accordance with GAAP. The measure is used as a supplement to GAAP results in evaluating certain aspects of Danimer's business, as described below.

Adjusted gross profit is defined as gross profit plus depreciation, stock-based compensation and other nonrecurring items.

Adjusted gross margin is defined as adjusted gross profit divided by total revenue.

Danimer believes that each of Adjusted EBITDA, Adjusted gross profit and Adjusted gross margin is useful to investors in evaluating the Company's performance because each measure considers the performance of the Company's operations, excluding decisions made with respect to capital investment, financing and other non-recurring charges as outlined in the preceding paragraph. Danimer believes these non-GAAP metrics offer additional financial information that, when coupled with the GAAP results and the reconciliation to GAAP results, provides a more complete understanding of its results of operations and the factors and trends affecting its business.

Adjusted EBITDA, Adjusted gross profit and Adjusted gross margin should not be considered as an alternative to net income or loss as an indicator of its performance or as alternatives to any other measure prescribed by GAAP as there are limitations to using such non-GAAP measures. Although Danimer believes that Adjusted EBITDA, Adjusted gross profit and Adjusted gross margin may enhance an evaluation of its operating performance based on recent revenue generation and product/overhead cost control because it excludes the impact of prior decisions made about capital investment, financing and other expenses, (i) other companies in Danimer's industry may define Adjusted EBITDA, Adjusted gross profit and Adjusted gross margin differently than Danimer does and, as a result, they may not be comparable to similarly titled measures used by other companies in its industry, and (ii) Adjusted EBITDA, Adjusted gross profit and Adjusted gross margin exclude certain financial information that some may consider important in evaluating Danimer's performance.

Danimer compensates for these limitations by providing disclosure of the differences between Adjusted EBITDA, Adjusted gross profit and Adjusted gross margin and GAAP results, including providing a reconciliation to GAAP results, to enable investors to perform their own analysis of Danimer's operating results. Because GAAP financial measures on a forward-looking basis are not accessible, and reconciling information is not available without unreasonable effort, reconciliations to GAAP financial measures are not provided for forward-looking non-GAAP measures. For the same reasons, the Company is unable to address the probable significance of the unavailable information, which could be material to future results.

 
                         Danimer Scientific, Inc. 
        Reconciliation of Adjusted EBITDA to Net Loss (Unaudited) 
 
                                         Three Months Ended March 31, 
                                    -------------------------------------- 
                                              2024                2023 
                                        ----------  ---      --------- 
(in thousands) 
Net loss                             $     (27,263)       $    (36,639) 
    Interest, net                            8,838               3,386 
    Depreciation and amortization            7,531               7,579 
    Stock-based compensation                   966              14,943 
    Transaction and other related              867                   - 
    Litigation and other legal 
     related                                   321                  57 
    Strategic reorganization and 
     related                                   176                   - 
    (Gain) loss on remeasurement 
     of warrants                               (99)              1,116 
    Income taxes                                 2                 (90) 
    Loss on extinguishment of 
     royalty agreement                           -                 549 
    Loss on sale of assets                       -                 247 
                                        ----------  ---      --------- 
Adjusted EBITDA                      $      (8,661)       $     (8,852) 
                                        ----------           --------- 
 
 
   Reconciliation of Adjusted Gross Profit to Gross Profit (Unaudited) 
 
                                         Three Months Ended March 31, 
                                    -------------------------------------- 
                                           2024                2023 
                                        ----------  ---      --------- 
(in thousands) 
Total revenue                        $      10,224        $     11,926 
Cost of revenue                             16,535              18,209 
                                        ----------  ---      --------- 
Gross profit                                (6,311)             (6,283) 
    Depreciation                             5,147               5,213 
    Loss on sale of assets                       -                  77 
    Stock-based compensation                     3                   2 
                                        ----------  ---      --------- 
Adjusted gross profit                $      (1,161)       $       (991) 
                                        ==========           ========= 
 
Adjusted gross margin                        -11.4%               -8.3% 
                                        ==========           ========= 
 

View source version on businesswire.com: https://www.businesswire.com/news/home/20240507485028/en/

 
    CONTACT:    Investors 

Blake Chamblee

Phone: 770-337-6570

ir@danimer.com

Media

Richard Ivey

Phone: 229-254-7688

rivey@danimer.com

 
 

(END) Dow Jones Newswires

May 07, 2024 16:01 ET (20:01 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment